Future Ink Corporation develops, manufactures, and markets printed electronics related products. It offers an n-type organic semiconductor material that is soluble in organic solvents. Future Ink Corporation was founded in 2016 and is based in Yonezawa, Japan.
Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, specializing in metabolomics technologies and solutions applicable to drug discovery, diagnosis, and food production. The company offers a range of services, including metabolome analysis, global profiling, targeted assays, flux analysis, and lipidomics. It is actively engaged in developing biomarkers, such as Phosphorylethanolamine, which is associated with major depressive disorder and can be detected in blood plasma. HMT's work spans various applications, including cancer metabolism, metabolic flux analysis, basic science, preclinical and clinical research, food and nutrition, and microbiome studies. The company collaborates with institutions like the Institute for Advanced Biosciences and Keio University to advance metabolome analysis technology. Founded in 2003, HMT continues to contribute to the field of biotechnology through its innovative research and diagnostic capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.